U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07417631) titled 'Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.' on Feb. 11.
Brief Summary: Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Study Start Date: Feb. 03
Study Type: OBSERVATIONAL
Condition:
Type 2 Diabetes
Intervention:
DRUG: Dulaglutide
Initiation of dulaglutide dispensing claim is used as the exposure.
DRUG: Sitagliptin
Initiation of sit...